How to calculate Low-Density Lipoprotein (LDL) in a non-fasting state?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating LDL in Nonfasting State

For most clinical scenarios, nonfasting lipid profiles are acceptable for LDL calculation, and the standard Friedewald formula can be used when triglycerides are <400 mg/dL. 1

Standard Methods for LDL Calculation

Friedewald Formula (Standard Method)

  • LDL-C = Total Cholesterol - HDL-C - (Triglycerides/5)
  • This is valid when triglycerides are <400 mg/dL (<4.5 mmol/L)
  • In nonfasting samples, this remains accurate for most patients 1, 2

When to Use Direct LDL-C Measurement

Direct measurement of LDL-C (or modified LDL-C estimation) is recommended when:

  1. Triglycerides ≥400 mg/dL (≥4.5 mmol/L) 1
  2. LDL-C levels are very low (<70 mg/dL or <1.8 mmol/L) 1, 3
  3. Patient has Type III dyslipidemia (dysbetalipoproteinemia) 4

Alternative Calculation Methods

Martin-Hopkins Method

  • Uses a 180-cell stratification of TG/non-HDL-C to determine the TG:VLDL-C ratio
  • More accurate for low LDL-C levels (<70 mg/dL) and when triglycerides are between 150-399 mg/dL
  • Valid in nonfasting state
  • Can be used with triglycerides up to 4.5 mmol/L 3, 5

Sampson-NIH2 Equation

  • Uses beta-quantification and multiple least squares regression
  • Can be used with triglycerides up to 9 mmol/L
  • Particularly useful in hypertriglyceridemia 5

Impact of Nonfasting State on Lipid Values

Nonfasting lipid profiles show minimal clinically significant differences compared to fasting samples:

  • Total Cholesterol: -0.2 mmol/L (8 mg/dL) lower
  • LDL Cholesterol: -0.2 mmol/L (8 mg/dL) lower (approximately 10%)
  • HDL Cholesterol: -0.1 mmol/L (4 mg/dL) lower
  • Triglycerides: +0.3 mmol/L (26 mg/dL) higher (up to 20%) 2

Clinical Algorithm for LDL Calculation in Nonfasting State

  1. For routine assessment in most patients:

    • Use nonfasting lipid profile
    • Calculate LDL-C using Friedewald formula
  2. If initial nonfasting triglycerides ≥400 mg/dL:

    • Repeat lipid profile in fasting state 1
    • If still ≥400 mg/dL, use direct LDL-C measurement
  3. If LDL-C is <70 mg/dL:

    • Consider using Martin-Hopkins method or direct LDL-C measurement for improved accuracy 1, 3
  4. For patients with suspected familial hyperlipidemia or genetic disorders:

    • Use fasting lipid profile for initial evaluation 1
  5. For monitoring lipid-lowering therapy:

    • Initial follow-up (4-8 weeks after starting therapy): fasting lipid profile
    • Long-term stable therapy: nonfasting lipid profile is acceptable 2

Special Considerations

  • When triglycerides are very low (<50 mg/dL) with high cholesterol, Friedewald formula may overestimate LDL-C; direct measurement is preferred 6
  • Sample freezing can affect direct LDL-C measurement (15.1% decrease after 30 days of freezing) 4
  • Non-HDL cholesterol (Total Cholesterol - HDL Cholesterol) can be used as an alternative marker, especially when triglycerides are elevated 1

Remember that nonfasting lipid testing improves patient compliance, reduces laboratory congestion, and better reflects the body's typical metabolic state, with minimal impact on clinical decision-making for most patients 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lipid Testing and Fasting Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

More accurate LDL-C calculation: Externally validated, guideline endorsed.

Clinica chimica acta; international journal of clinical chemistry, 2020

Research

Best practice for LDL-cholesterol: when and how to calculate.

Journal of clinical pathology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.